[1] N. Acosta-Rivero, J. C. Aguilar, A. Musacchio, V. Falcon, A. Vina, M. C. de la RosaJ. Morales, Characterization of the HCV core virus-like particles produced in the methylotrophic yeast Pichia pastoris, Biochem. Biophys. Res. Commun. 287 (1) (2001) 122-125.
[2] S. Acton, A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, M. Krieger, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science 271 (5248) (1996) 518-520.
[3] V. Agnello, G. Abel, M. Elfahal, G. B. Knight, Q. X. Zhang, Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor, Proc. Natl. Acad. Sci. U. S. A. 96 (22) (1999) 12766-12771.
[4] H. Ago, T. Adachi, A. Yoshida, M. Yamamoto, N. Habuka, K. Yatsunami, M. Miyano, Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus, Structure Fold Des 7 (11) (1999) 1417-1426.
[5] H. Aizaki, S. Nagamori, M. Matsuda, H. Kawakami, O. Hashimoto, H. Ishiko, M. Kawada, T. Matsuura, S. Hasumura, Y. Matsuura, T. Suzuki, T. Miyamura. Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 314 (1) (2003) 16-25.
[6] H. Aizaki, K. J. Lee, V. M. Sung, H. Ishiko, M. M. Lai, Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts, Virology 324 (2) (2004) 450-461.
[7] H. Aizaki, K. S. Choi, M. Liu, Y. J. Li, M. M. Lai, Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis, J. Biomed. Sci. 13 (4) (2006) 469-480.
[8] D. Akazawa, T. Date, K. Morikawa, A. Murayama, M. Miyamoto, M. Kaga, H. Barth, T.F. Baumert, J. Dubuisson, T. Wakita. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol. 81 (10) (2007) 5036-45.
[9] N. Ali, A. Siddiqui, Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation, J. Virol. 69 (10) (1995) 6367-6375.
[10] N. Ali, G. J. Pruijn, D. J. Kenan, J. D. Keene, A. Siddiqui, Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation, J. Biol. Chem. 275 (36) (2000) 27531-27540.
[11] N. Ali, K. D. Tardif, A. Siddiqui, Cell-free replication of the hepatitis C virus subgenomic replicon, J Virol 76 (23) (2002) 12001-12007.
[12] M. J. Alter, Epidemiology of hepatitis C in the West, Semin. Liver Dis. 15 (1) (1995) 5-14.
[13] P. Andre, F. Komurian-Pradel, S. Deforges, M. Perret, J. L. Berland, M. Sodoyer, S. Pol, C. Brechot, G. Paranhos-Baccala, V. Lotteau, Characterization of low- and very-low-density hepatitis C virus RNA-containing particles, J. Virol. 76 (14) (2002) 6919-6928.
[14] A. Anwar, N. Ali, R. Tanveer, A. Siddiqui, Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation, J. Biol. Chem. 275 (44) (2000) 34231-34235.
[15] N. Appel, T. Pietschmann, R. Bartenschlager. Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol. 79 (5) (2005) 3187-94.
[16] N. Appel, M. Zayas, S. Miller, J. Krijnse-Locker, T. Schaller, P. Friebe, S. Kallis, U. Engel, R. Bartenschlager. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 4 (3) (2008) e1000035.
[17] G. Barba, F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura, C. Brechot, Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets, Proceedings of the National Academy of Sciences, U. S. A. 94 (1997) 1200-1205.
[18] R. Bartenschlager, L. Ahlborn-Laake, J. MousH. Jacobsen, Kinetic and structural analyses of hepatitis C virus polyprotein processing, J. Virol. 68 (1994) 5045-5055.
[19] H. Barth, R. Cerino, M. Arcuri, M. Hoffmann, P. Schurmann, M. I. Adah, B. Gissler, X. Zhao, V. Ghisetti, B. Lavezzo, H. E. Blum, F. von Weizsacker, A. Vitelli, E. Scarselli, T. F. Baumert, Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes, J. Virol. 79 (9) (2005) 5774-5785.
[20] B. Bartosch, J. Bukh, J. C. Meunier, C. Granier, R. E. Engle, W. C. Blackwelder, S. U. Emerson, F. L. Cosset, R. H. Purcell, In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes, Proc. Natl. Acad. Sci. U. S. A. 100 (24) (2003) 14199-14204.
[21] B. Bartosch, J. Dubuisson, F. L. Cosset, Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes, J. Exp. Med. 197 (5) (2003) 633-642.
[22] B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson, S. Pascale, E. Scarselli, R. Cortese, A. Nicosia, F. L. Cosset, Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor, J. Biol. Chem. 278 (43) (2003) 41624-41630.
[23] B. Bartosch, G. Verney, M. Dreux, P. Donot, Y. Morice, F. Penin, J. M. Pawlotsky, D. Lavillette, F. L. Cosset, An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies, J. Virol. 79 (13) (2005) 8217-8229.
[24] T. F. Baumert, S. Ito, D. T. Wong, T. J. Liang, Hepatitis C virus structural proteins assemble into viruslike particles in insect cells, J. Virol. 72 (5) (1998) 3827-3836.
[25] S. Bavari, C.M. Bosio, E. Wiegand, G. Ruthel, A.B. Will, T.W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, M.J. Aman, Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med l95 (2002) 593-602.
[26] A. Op De Beeck, L. Cocquerel, J. Dubuisson, Biogenesis of hepatitis C virus envelope glycoproteins, J. Gen. Virol. 82 (Pt 11) (2001) 2589-2595.
[27] M. Di Bisceglie, Hepatitis C and hepatocellular carcinoma, Hepatology 26 (3 Suppl 1) (1997) 34S-38S.
[28] E. Blanchard, C. Hourioux, D. Brand, M. Ait-Goughoulte, A. Moreau, S. Trassard, P. Y. Sizaret, F. Dubois, P. Roingeard, Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111, J. Virol. 77 (18) (2003) 10131-10138.
[29] K. J. Blight, A. A. Kolykhalov, C. M. Rice, Efficient initiation of HCV RNA replication in cell culture, Science 290 (2000) 1972-1974.
[30] M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, S. Crotta. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol. 82 (17) (2008) 8316-29.
[31] S. Bressanelli, L. Tomei, F. A. Rey, R. De Francesco, Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides, J. Virol. 76 (7) (2002) 3482-3492.
[32] J.A. Briggs, T. Wilk, S.D. FuUer. Do lipid rafts mediate virus assembly and pseudotyping? J Gen Virol、84 (2003) 757-768.
[33] E. A. Brown, H. Zhang, L. H. Ping, S. M. Lemon, Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs, Nucleic Acids Res. 20 (19) (1992) 5041-5045.
[34] G. Brown, H.W. Rixon, R.J. Sugrue. Respiratorysyncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1、J Gen Virol. 83 (2002) 1841-1850.
[35] J. Bukh, R. H. Purcell, R. H. Miller, Sequence analysis of the 5' noncoding region of hepatitis C virus, Proc. Natl. Acad. Sci. U. S. A. 89 (11) (1992) 4942-4946.
[36] T. Burckstummer, M. Kriegs, J. Lupberger, E. K. Pauli, S. Schmittel, E. Hildt, Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication, FEBS Lett. 580 (2) (2006) 575-580.
[37] S. J. Butcher, J. M. Grimes, E. V. Makeyev, D. H. Bamford, D. I. Stuart, A mechanism for initiating RNA-dependent RNA polymerization, Nature 410 (6825) (2001) 235-240.
[38] K.S. Chang, J. Jiang, Z. Cai, G. Luo. Human apoilpoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol. 81 (2007) 13783-13793.
[39] N. Chazal N, D. Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev. 67 (2) (2003) 226-37.
[40] Q.-L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, M. Houghton, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science 244 (1989) 359-362.
[41] K. M. Chung, J. Lee, J. E. Kim, O. K. Song, S. Cho, J. Lim, M. Seedorf, B. Hahm, S. K. Jang, Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3, J. Virol. 74 (11) (2000) 5233-5241.
[42] L. Cocquerel, A. Op de Beeck, M. Lambot, J. Roussel, D. Delgrange, A. Pillez, C. Wychowski, F. Penin, J. Dubuisson, Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins, EMBO J. 21 (12) (2002) 2893-2902.
[43] R.W. Compans, N.J. Dimmock, An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus. Virology 39 (1969) 499-515.
[44] E. G. Cormier, F. Tsamis, F. Kajumo, R. J. Durso, J. P. Gardner, T. Dragic, CD81 is an entry coreceptor for hepatitis C virus, Proc. Natl. Acad. Sci. U. S. A. 101 (19) (2004) 7270-7274.
[45] E. G. Cormier, R. J. Durso, F. Tsamis, L. Boussemart, C. Manix, W. C. Olson, J. P. Gardner, T. Dragic, L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus, Proc. Natl. Acad. Sci. U. S. A. 101 (39) (2004) 14067-14072.
[46] M. Dimitrova, I. Imbert, M. P. Kieny, C. Schuster, Protein-protein interactions between hepatitis C virus nonstructural proteins, J. Virol. 77 (9) (2003) 5401-5414.
[47] S. Dumont, W. Cheng, V. Serebrov, R. K. Beran, I. Tinoco, Jr., A. M. Pyle, C. Bustamante, RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP, Nature 439 (7072) (2006) 105-108.
[48] D. Egger, B. Wolk, R. Gosert, L. Bianchi, H. E. Blum, D. Moradpour, K. Bienz, Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex, J. Virol. 76 (12) (2002) 5974-5984.
[49] M. J. Evans, T. von Hahn, D. M. Tscherne, A. J. Syder, M. Panis, B. Wolk, T. Hatziioannou, J. A. McKeating, P. D. Bieniasz, C. M. Rice, Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature 446 (7137) (2007) 801-805.
[50] H. J. Ezelle, D. Markovic, G. N. Barber, Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector, J. Virol. 76 (23) (2002) 12325-12334.
[51] C. Failla, L. Tomei, R. De Francesco, An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A, J. Virol. 69 (3) (1995) 1769-1777.
[52] X. Feng, N.V. Heyden, L. Ratner, Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts、J Virol. 77 (2003) 13389-13395.
[53] R. De Francesco, G. Migliaccio, Challenges and successes in developing new therapies for hepatitis C, Nature 436 (7053) (2005) 953-960.
[54] D. N. Frick, R. S. Rypma, A. M. Lam, B. Gu, The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently, J. Biol. Chem. 279 (2) (2004) 1269-1280.
[55] P. Friebe, V. Lohmann, N. Krieger, R. Bartenschlager, Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication, J. Virol. 75 (24) (2001) 12047-12057.
[56] P. Friebe, R. Bartenschlager, Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication, J. Virol. 76 (11) (2002) 5326-5338.
[57] I S. Fukushi, M. Okada, T. Kageyama, F. B. Hoshino, K. Nagai, K. Katayama, Interaction of poly(rC)-binding protein 2 with the 5'-terminal stem loop of the hepatitis C-virus genome, Virus Res. 73 (1) (2001) 67-79.
[58] L. Gao, H. Aizaki, J. W. He, M. M. Lai, Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft, J. Virol. 78 (7) (2004) 3480-3488.
[59] J. P. Gardner, R. J. Durso, R. R. Arrigale, G. P. Donovan, P. J. Maddon, T. Dragic, W. C. Olson, L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus, Proc. Natl. Acad. Sci. U. S. A. 100 (8) (2003) 4498-4503.
[60] P. Gastaminza, G. Cheng, S. Wieland, J. Zhong, W. Liao, F.V. Chisari. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol. 82 (2007) 2120-2129.
[61] K. Ghosh, M. Majumder, R. Steele, P. Yaciuk, J. Chrivia, R. Ray, R. B. Ray, Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP, J. Biol. Chem. 275 (10) (2000) 7184-7188.
[62] P. Y. Goh, Y. J. Tan, S. P. Lim, Y. H. Tan, S. G. Lim, F. Fuller-Pace, W. Hong, Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication, J. Virol. 78 (10) (2004) 5288-5298.
[63] A. Grakoui, H. L. Hanson, C. M. Rice, Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis, Hepatology 33 (3) (2001) 489-495.
[64] S. D. Griffin, L. P. Beales, D. S. Clarke, O. Worsfold, S. D. Evans, J. Jaeger, M. P. Harris, D. J. Rowlands, The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine, FEBS Lett. 535 (1-3) (2003) 34-38.
[65] B. Hahm, Y. K. Kim, J. H. Kim, T. Y. Kim, S. K. Jang, Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus, J. Virol. 72 (11) (1998) 8782-8788.
[66] I. Hamamoto, Y. Nishimura, T. Okamoto, H. Aizaki, M. Liu, Y. Mori, T. Abe, T. Suzuki, M. M. Lai, T. Miyamura, K. Moriishi, Y. Matsuura, Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B, J. Virol. 79 (21) (2005) 13473-13482.
[67] S. Harada, Y. Watanabe, K. Takeuchi, T. Suzuki, T. Katayama, Y. Takebe, I. Saito, T. Miyamura, Expression of processed core protein of hepatitis C virus in mammalian cells, J. Virol. 65 (1991) 3015-3021.
[68] R. W. Hardy, J. Marcotrigiano, K. J. Blight, J. E. Majors, C. M. Rice, Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells, J. Virol. 77 (3) (2003) 2029-2037.
[69] U. Hellen, T. V. Pestova, Translation of hepatitis C virus RNA, J. Viral Hepat. 6 (2) (1999) 79-87.
[70] G. Henderson, L. Murray, R.P. Yeo. Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-sulface expression of the glycoproteins, Virology 300 (2002) 244-254.
[71] M. Hijikata, N. Kato, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, K. Shimotohno, Hypervariable regions in the putative glycoprotein of hepatitis C virus, Biochem. Biophys. Res. Commun. 175 (1991) 220-228.
[72] M. Hirano, S. Kaneko, T. Yamashita, H. Luo, W. Qin, Y. Shirota, T. Nomura, K. Kobayashi, S. Murakami, Direct interaction between nucleolin and hepatitis C virus NS5B, J. Biol. Chem. 278 (7) (2003) 5109-5115.
[73] M. Honda, M. R. Beard, L. H. Ping, S. M. Lemon, A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation, J. Virol. 73 (2) (1999) 1165-1174.
[74] M. Honda, E. A. Brown, S. M. Lemon, Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA, RNA 2 (10) (1996) 955-968.
[75] R. G. Hope, J. McLauchlan, Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein, J Gen Virol 81 (Pt 8) (2000) 1913-1925.
[76] M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-Mayer, C. M. Rice, J. A. McKeating, Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proc. Natl. Acad. Sci. U. S. A. 100 (12) (2003) 7271-7276.
[77] H. Huang, Y. Chen, J. Ye. Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc Natl Acad Sci U S A. 104 (47) (2007) 18666-70.
[78] P. Hüssy, H. Langen, J. Mous, H. Jacobsen, Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase, Virology 224 (1996) 93-104.
[79] M. Ikeda, K. Abe, M. Yamada, H. Dansako, K. Naka, N. Kato, Different anti-HCV profiles of statins and their potential for combination therapy with interferon, Hepatology 44 (1) (2006) 117-125.
[80] K. Ishii, K. Murakami, S.S. Hmwe, B. Zhang, J. Li, M. Shirakura, K. Morikawa, R. Suzuki,T. Miyamura, T. Wakita, T. Suzuki. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochem Biophys Res Commun. 371 (3) (2008) 446-50.
[81] N. Ishii, K. Watashi, T. Hishiki, K. Goto, D. Inoue, M. Hijikata, T. Wakita, N. Kato, K. Shimotohno. Diverse effects of cyclosporine on hepatitis C virus strain replication. J Virol. 80 (9) (2006) 4510-20.
[82] T. Isoyama, N. Kamoshita, K. Yasui, A. Iwai, K. Shiroki, H. Toyoda, A. Yamada, Y. Takasaki, A. Nomoto, Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA, J. Gen. Virol. 80 ( Pt 9) (1999) 2319-2327.
[83] T. Ito, M. M. Lai, Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome, J. Virol. 71 (11) (1997) 8698-8706.
[84] T. Ito, M. M. Lai, An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence, Virology 254 (2) (1999) 288-296.
[85] T. Iwahori, T. Matsuura, H. Maehashi, K. Sugo, M. Saito, M. Hosokawa, K. Chiba, T. Masaki, H. Aizaki, K. Ohkawa, T. Suzuki. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology (3) (2003) 665-73.
[86] V. Jirasko, R. Montserrent, N. Appel, A. Janvier, I. Eustachi, C. Brohm, E. Steinmann, T. Pietschmann, F. Penin, R. Bartenschlager. Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem. 283 (2008) 28546-28562.
[87] C.T. Jones, C.L. Murray, D.K. Eastmann, J. Tassello, C.M. Rice. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol. 81 (2007) 8374-8383.
[88] L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, P. Sarnow, Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA, Science 309 (5740) (2005) 1577-1581.
[89] M. Kaito, S. Wastanabe, K. Tsukiyama-Kohara, K. Yamaguchi, Y. Kobayashi, M. Konishi, M. Yokoi, S. Ishida, S. Suzuki, M. Kohara, Hepatitis C virus particle detected by immunoelectron microscopic study, J. Gen. Virol. 75 (1994) 1755-1760.
[90] S. B. Kapadia, F. V. Chisari, Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids, Proc. Natl. Acad. Sci. U. S. A. 102 (7) (2005) 2561-2566.
[91] N. Kato, Y. Ootsuyama, T. Tanaka, M. Nakagawa, T. Nakazawa, K. Muraiso, S. Ohkoshi, M. Hijikata, K. Shimotohno, Marked sequence diversity in the putative envelope proteins of hepatitis C viruses, Virus Res. 22 (1992) 107-123.
[92] T. Kato, T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, M. Mizokami, T. Wakita. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125 (6) (2003) 1808-17.
[93] M. Kawada, S. Nagamori, H. Aizaki, K. Fukaya, M. Niiya, T. Matsuura, H. Sujino, S. Hasumura, H. Yashida, S. Mizutani, H. Ikenaga. Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines. In Vitro Cell Dev Biol Anim. 34 (2) (1998) 109-15.
[94] A. Khromykh, E. G. Westaway, Subgenomic replicons of the flavivirus Kunjin: construction and applications, J. Virol. 71 (2) (1997) 1497-1505.
[95] L. Kim, K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, J. A. Thomson, Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide, Cell 87 (1996) 343-355.
[96] L. Kim, K. A. Morgenstern, J. P. Griffith, M. D. Dwyer, J. A. Thomson, M. A. Murcko, C. Lin, P. R. Caron, Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding, Structure 6 (1) (1998) 89-100.
[97] S. Kim, S. K. Seol, O. K. Song, J. H. Park, S. K. Jang, An RNA-Binding Protein, hnRNP A1, and a Scaffold Protein, Septin 6, Facilitate Hepatitis C Virus Replication, J. Virol. 81 (8) (2007) 3852-3865.
[98] C. Klein, S. J. Polyak, J. R. Lingappa, Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly, J. Virol. 78 (17) (2004) 9257-9269.
[99] A. Kolykhalov, E. V. Agapov, K. J. Blight, K. Mihalik, S. M. Feinstone, C. M. Rice, Transmission of hepatitis C by intrahepatic inoculation with transcibed RNA, Science 277 (1997) 570-574.
[100] A. Kolykhalov, K. Mihalik, S. M. Feinstone, C. M. Rice, Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo, J. Virol. 74 (2000) 2046-2051.
[101] G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, T. Pietschmann. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol. 81 (2) (2007) 588-98.
[102] N. Krieger, V. Lohmann, R. Bartenschlager, Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations, J Virol 75 (10) (2001) 4614-4624.
[103] M. Kunkel, M. Lorinczi, R. Rijnbrand, S. M. LemonS. J. Watowich, Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein, J Virol 75 (5) (2001) 2119-2129.
[104] G. Kuo, Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, F. R. Shuster, L. R. Overby, D. W. Bradley, M. Houghton, An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science 244 (1989) 362-364.
[105] D. Kwong, J. L. Kim, C. Lin, Structure and function of hepatitis C virus NS3 helicase, Curr Top Microbiol Immunol 242 (2000) 171-196.
[106] L. M. Lagging, K. M. Randall, J. Owens, R. Ray, Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus, J. Virol. 72 (1998) 3539-3546.
[107] V. C. Lai, S. Dempsey, J. Y. Lau, Z. Hong, W. Zhong, In vitro RNA replication directed by replicase complexes isolated from the subgenomic replicon cells of hepatitis C virus, J. Virol. 77 (3) (2003) 2295-2300.
[108] M.M. Lai. Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription. Virology 244 (1) (1998) 1-12.
[109] K. T. Landschulz, R. K. Pathak, A. Rigotti, M. Krieger, H. H. Hobbs, Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat, J. Clin. Invest. 98 (4) (1996) 984-995.
[110] G. M. Lauer, B. D. Walker, Hepatitis C virus infection, N. Engl. J. Med. 345 (1) (2001) 41-52.
[111] D. Lavillette, A. W. Tarr, C. Voisset, P. Donot, B. Bartosch, C. Bain, A. H. Patel, J. Dubuisson, J. K. Ball, F. L. Cosset, Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus, Hepatology 41 (2) (2005) 265-274.
[112] D. D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier, E. Pagkalos, G. Sakellariou, L. Intrator, B. Bartosch, J. M. Pawlotsky, F. L. Cosset, Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection, J. Virol. 79 (10) (2005) 6023-6034.
[113] B. Lee, M. Sharron, L.J. Montaner, D. Weissman, R.W. Doms. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci USA 96 (1999) 5215-5220.
[114] G.E. Lee, G.A. Church, D.W. Wilson. A subpopulation of tegument protein vhs localizes to detergent-insoluble lipid rafts in herpes simplex virus-infected cells. J Virol. 77 (2003) 2038-2045.
[115] M. K. Lemberg, B. Martoglio, Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis, Mol. Cell 10 (4) (2002) 735-744.
[116] M. Yi, S. M. Lemon, 3' nontranslated RNA signals required for replication of hepatitis C virus RNA, J. Virol. 77 (6) (2003) 3557-3568.
[117] A. Lesburg, M. B. Cable, E. Ferrari, Z. Hong, A. F. Mannarino, P. C. Weber, Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site, Nat. Struct. Mol. Biol. 6 (10) (1999) 937-943.
[118] M. K. Levin, M. Gurjar, S. S. Patel, A Brownian motor mechanism of translocation and strand separation by hepatitis C virus helicase, Nat. Struct. Mol. Biol. 12 (5) (2005) 429-435.
[119] S. Levy, S. C. Todd, H. T. Maecker, CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system, Annual Review of Immunology 16 (1998) 89-109.
[120] D. Li, S. T. Takyar, W. B. LottE. J. Gowans, Amino acids 1-20 of the hepatitis C virus (HCV) core protein specifically inhibit HCV IRES-dependent translation in HepG2 cells, and inhibit both HCV IRES- and cap-dependent translation in HuH7 and CV-1 cells, J Gen Virol 84 (Pt 4) (2003) 815-825.
[121] X.D. Li, L. Sun, R.B. Seth, G. Pineda, Z.J. Chen. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A. 102 (49) (2005) 17717-22.
[122] C. Lin, B. M. Pragai, A. Grakoui, J. Xu, C. M. Rice, Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics, J. Virol. 68 (1994) 8147-8157.
[123] D. Lindenbach, M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, C. M. Rice, Complete replication of hepatitis C virus in cell culture, Science 309 (5734) (2005) 623-626.
[124] B.D. Lindenbach, P. Meuleman, A. Ploss, T. Vanwolleghem, A.J. Syder, J.A. McKeating, R.E. Lanford, S.M. Feinstone, M.E. Major, G. Leroux-Roels, C.M. Rice. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A. 103 (10) (2006) 3805-9.
[125] O.W. Lindwasser, M.D. Resh, Multimerization of human immunodeficiency virus type1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol. 75 (2001) 7913-7924.
[126] Q. Liu, C. Tackney, R. A. Bhat, A. M. Prince, P. Zhang, Regulated processing of hepatitis C virus core protein is linked to subcellular localization, J. Virol. 71 (1) (1997) 657-662.
[127] S.-Y. Lo, M. J. Selby, J.-H. Ou, Interaction between hepatitis C virus core protein and E1 envelope protein, J. Virol. 70 (1996) 5177-5182.
[128] V. Lohmann, F. Korner, J. Koch, U. Herian, L. TheilmannR. Bartenschlager, Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line, Science 285 (1999) 110-113.
[129] V. Lohmann, F. Korner, A. Dobierzewska, R. Bartenschlager, Mutations in hepatitis C virus RNAs conferring cell culture adaptation, J. Virol. 75 (3) (2001) 1437-1449.
[130] C. Lorenz, J. Marcotrigiano, T. G. Dentzer, C. M. Rice, Structure of the catalytic domain of the hepatitis C virus NS2-3 protease, Nature 442 (7104) (2006) 831-835.
[131] L. J. Lorenzo, S. Duenas-Carrera, V. Falcon, N. Acosta-Rivero, E. Gonzalez, M. C. de la Rosa, I. Menendez, J. Morales, Assembly of truncated HCV core antigen into virus-like particles in Escherichia coli, Biochem. Biophys. Res. Commun. 281 (4) (2001) 962-965.
[132] R. A. Love, H. E. Parge, J. A. Wickersham, Z. Hostomsky, N. Habuka, E. W. Moomaw, T. Adachi, Z. Hostomska, The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site, Cell 87 (1996) 331-342.
[133] Y. Lozach, H. Lortat-Jacob, A. de Lacroix de Lavalette, I. Staropoli, S. Foung, A. Amara, C. Houles, F. Fieschi, O. Schwartz, J. L. Virelizier, F. Arenzana-Seisdedos, R. Altmeyer, DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J Biol Chem 278 (22) (2003) 20358-20366.
[134] Y. Lozach, A. Amara, B. Bartosch, J. L. Virelizier, F. Arenzana-Seisdedos, F. L. Cosset, R. Altmeyer, C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles, J Biol Chem 279 (31) (2004) 32035-32045.
[135] H. H. Lu, E. Wimmer, Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus, Proc. Natl. Acad. Sci. U. S. A. 93 (4) (1996) 1412-1417.
[136] X. Lu, J. Silver. Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology 276 (2000) 251-258.
[137] M. Lundin, M. Monne, A. Widell, G. Von Heijne, M. A. Persson, Topology of the membrane-associated hepatitis C virus protein NS4B, J Virol 77 (9) (2003) 5428-5438.
[138] H. C. Ma, C. H. Ke, T. Y. Hsieh, S. Y. Lo, The first hydrophobic domain of the hepatitis C virus E1 protein is important for interaction with the capsid protein, J. Gen. Virol. 83 (Pt 12) (2002) 3085-3092.
[139] P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, A. Budkowska, Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients, J. Virol. 75 (17) (2001) 8240-8250.
[140] N. Majeau, V. Gagne, A. Boivin, M. Bolduc, J. A. Majeau, D. Ouellet, D. Leclerc, The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation, J. Gen. Virol. 85 (Pt 4) (2004) 971-981.
[141] S. Manes, G. del Real, R.A. Lacalle, P. Lucas, C. Gomez-Mouton, S. Sanchez-Palomino, R. Delgado, L. Alcami, E. Mira, C. Martinez-A. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection EMBO Rep、1 (2000) 190-196.
[142] S.N. Manie, S. Debreyne, S. Vincent, D. Gerlier、Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly、J Virol 74 (2000) 305-311.
[143] M. Martell, J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, J. Gomez, Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution, J. Virol. 66 (1992) 3225-3229.
[144] M. Matsumoto, S. B. Hwang, K. S. Jeng, N. Zhu, M. M. Lai, Homotypic interaction and multimerization of hepatitis C virus core protein, Virology 218 (1) (1996) 43-51.
[145] E. Matsuo, H. Tani, C. Lim, Y. Komoda, T. Okamoto, H. Miyamoto, K. Moriishi, S. Yagi, A. H. Patel, T. Miyamura, Y. Matsuura, Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus, Biochem. Biophys. Res. Commun. 340 (1) (2006) 200-208.
[146] T. Matsuura, M. Kawada, S. Hasumura, S. Nagamori, T. Obata, M. Yamaguchi, Y. Hataba, H. Tanaka, H. Shimizu, Y. Unemura, K. Nonaka, T. Iwaki, S. Kojima, H. Aizaki, S. Mizutani, H. Ikenaga. High density culture of immortalized liver endothelial cells in the radial-flow bioreactor in the development of an artificial liver. Int J Artif Organs 21 (4) (1998) 229-34.
[147] Y. Matsuura, H. Tani, K. Suzuki, T. Kimura-Someya, R. Suzuki, H. Aizaki, K. Ishii, K. Moriishi, C. S. Robison, M. A. Whitt, T. Miyamura, Characterization of pseudotype VSV possessing HCV envelope proteins, Virology 286 (2) (2001) 263-275.
[148] A. McKeating, L. Q. Zhang, C. Logvinoff, M. Flint, J. Zhang, J. Yu, D. Butera, D. D. Ho, L. B. Dustin, C. M. RiceP. Balfe, Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner, J. Virol. 78 (16) (2004) 8496-8505.
[149] J. McLauchlan, M. K. Lemberg, G. Hope, B. Martoglio, Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets, EMBO J. 21 (15) (2002) 3980-3988.
[150] C.J. Mee, J. Grove, H.J. Harris, K. Hu, P. Balfe, J.A. McKeating. Effect of cell polarization on hepatitis C virus entry. J Virol. 82 (1) (2008) 461-70.
[151] J. C. Meunier, R. E. Engle, K. Faulk, M. Zhao, B. Bartosch, H. Alter, S. U. Emerson, F. L. Cosset, R. H. Purcell, J. Bukh, Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proc. Natl. Acad. Sci. U. S. A. 102 (12) (2005) 4560-4565.
[152] J.C. Meunier, R.S. Russell, R.E. Engle, K.N. Faulk, R.H. Purcell, S.U. Emerson. Apolipoprotein c1 association with hepatitis C virus. J Virol. 82 (2008) 9647-9656.
[153] E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, J. Tschopp. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (7062) (2005) 1167-72.
[154] Y. Miyanari, M. Hijikata, M. Yamaji, M. Hosaka, H. Takahashi, K. Shimotohno, Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication, J. Biol. Chem. 278 (50) (2003) 50301-50308.
[155] Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, R. Bartenschlager, T. Wakita, M. Hijikata, K. Shimotohno. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 9 (9) (2007) 1089-97.
[156] D. Moradpour, C. Englert, T. Wakita, J.R. Wands. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology. 222 (1) (1996) 51-63.
[157] D. Moradpour, T. Wakita, K. Tokushige, R. I. Carlson, K. Krawczynski, J. R. Wands, Characterization of three novel monoclonal antibodies against hepatitis C virus core protein, J. Med. Virol. 48 (3) (1996) 234-241.
[158] D. Moradpour, V. Brass, E. Bieck, P. Friebe, R. Gosert, H. E. Blum, R. Bartenschlager, F. Penin, V. Lohmann, Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication, J. Virol. 78 (23) (2004) 13278-13284.
[159] K. Morikawa, Z. Zhao, T. Date, M. Miyamoto, A. Murayama, D. Akazawa, J. Tanabe, S. Sone, T. Wakita. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J Med Virol. 79 (6) (2007) 714-23.
[160] K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice, Nat. Med. 4 (1998) 1065-1067.
[161] G. Mottola, G. Cardinali, A. Ceccacci, C. Trozzi, L. Bartholomew, M. R. Torrisi, E. Pedrazzini, S. Bonatti, G. Migliaccio, Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons, Virology 293 (1) (2002) 31-43.
[162] K. Murakami, M. Abe, T. Kageyama, N. Kamoshita, A. Nomoto, Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3' untranslated region of RNA, Arch Virol 146 (4) (2001) 729-741.
[163] K. Murakami, K. Ishii, Y. Ishihara, S. Yoshizaki, K. Tanaka, Y. Gotoh, H. Aizaki, M. Kohara, H. Yoshioka, Y. Mori, N. Manabe, I. Shoji, T. Sata, R. Bartenschlager, Y. Matsuura, T. Miyamura, T. Suzuki, Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b, Virology 351 (2) (2006) 381-392.
[164] A. Murayama, T. Date, K. Morikawa, D. Akazawa, M. Miyamoto, M. Kaga, K. Ishii, T. Suzuki, T. Kato, M. Mizokami, T. Wakita. The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol. 81 (15) (2007) 8030-40.
[165] M. Nakagawa, N. Sakamoto, Y. Tanabe, T. Koyama, Y. Itsui, Y. Takeda, C.H. Chen, S. Kakinuma, S. Oooka, S. Maekawa, N. Enomoto, M. Watanabe. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Gastroenterology 129 (3) (2005) 1031-41.
[166] K. Nakai, T. Okamoto, T. Kimura-Someya, K. Ishii, C. K. Lim, H. Tani, E. Matsuo, T. Abe, Y. Mori, T. Suzuki, T. Miyamura, J. H. Nunberg, K. Moriishi, Y. Matsuura, Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein, J. Virol. 80 (22) (2006) 11265-11273.
[167] D.H. Nguyen, J.E. Hildreth. Evidence for budding of human ilnmunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol、74 (2000) 3264-3272.
[168] K. Niyogi, J.E. Hildreth. Characterization of new syncytium-inhibiting monoclonal antibodies implicates lipid rafts in human T-cell leukemia virus type1 syncytium formation、J Virol. 75 (2001) 7351-7361.
[169] O. Nolandt, V. Kern, H. Muller, E. Pfaff, L. Theilmann, R. Welker, H. G. Krausslich, Analysis of hepatitis C virus core protein interaction domains, J. Gen. Virol. 78 ( Pt 6) (1997) 1331-1340.
[170] K. Okamoto, K. Moriishi, T. Miyamura, Y. Matsuura, Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein, J. Virol. 78 (12) (2004) 6370-6380.
[171] T. Okamoto, Y. Nishimura, T. Ichimura, K. Suzuki, T. Miyamura, T. Suzuki, K. Moriishi, Y. Matsuura, Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90, EMBO J. 25 (20) (2006) 5015-5025.
[172] M. Okuda, K. Li, M. R. Beard, L. A. Showalter, F. Scholle, S. M. Lemon, S. A. Weinman, Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein, Gastroenterology 122 (2) (2002) 366-375.
[173] A. Ono, E.O. Freed. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci USA. 98 (2001) 13925-13930.
[174] A. Otto, J. D. Puglisi, The pathway of HCV IRES-mediated translation initiation, Cell 119 (3) (2004) 369-380.
[175] R.G. Panchal, G. Ruthel, T.A. Kenny, G.H. Kallstrom, D. Lane, S.S. Badie, L. Li, S. Bavari, M.J. Aman. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci USA.100 (2003) 15936-15941.
[176] D. Pavlovic, D. C. Neville, O. Argaud, B. Blumberg, R. A. Dwek, W. B. Fischer, N. Zitzmann, The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives, Proc. Natl. Acad. Sci. U. S. A. 100 (10) (2003) 6104-6108.
[177] J. M. Pawlotsky, Pathophysiology of hepatitis C virus infection and related liver disease, Trends Microbiol. 12 (2) (2004) 96-102.
[178] J. M. Pawlotsky, Hepatitis C virus population dynamics during infection, Curr. Top. Microbiol. Immunol. 299 (2006) 261-284.
[179] R. Petracca, F. Falugi, G. Galli, N. Norais, D. Rosa, S. Campagnoli, V. Burgio, E. Di Stasio, B. Giardina, M. Houghton, S. Abrignani, G. Grandi, Structure-function analysis of hepatitis C virus envelope-CD81 binding, J. Virol. 74 (10) (2000) 4824-4830.
[180] U. Pfeifer, R. Thomssen, K. Legler, U. Bottcher, W. Gerlich, E. Weinmann, O. Klinge, Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees, Virchows Arch B Cell Pathol Incl Mol Pathol 33 (3) (1980) 233-243.
[181] T. Pietschmann, V. Lohmann, G. Rutter, K. Kurpanek, R. Bartenschlager, Characterization of cell lines carrying self-replicating hepatitis C virus RNAs, J Virol 75 (3) (2001) 1252-1264.
[182] T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F. L. Cosset, R. Bartenschlager, Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proc. Natl. Acad. Sci. U. S. A. 103 (19) (2006) 7408-7413.
[183] P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, S. Abrignani, Binding of hepatitis C virus to CD81, Science 282 (1998) 938-941.
[184] S. Pohlmann, J. Zhang, F. Baribaud, Z. Chen, G. J. Leslie, G. Lin, A. Granelli-Piperno, R. W. Doms, C. M. Rice, J. A. McKeating, Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR, J. Virol. 77 (7) (2003) 4070-4080.
[185] W. Popik, T.M. Alce, W.C. Au, Human immunodeficiency virus type1uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol. 76 (2002) 4709-722.
[186] T. Poynard, M. F. Yuen, V. Ratziu, C. L. Lai, Viral hepatitis C, Lancet 362 (9401) (2003) 2095-2100.
[187] D. Quinkert, R. Bartenschlager, V. Lohmann. Quantitative analysis of the hepatitis C virus replication complex. J Virol. 79 (21) (2005) 13594-605.
[188] J. E. Reynolds, A. Kaminski, H. J. Kettinen, K. Grace, B. E. Clarke, A. R. Carroll, D. J. Rowlands, R. J. Jackson, Unique features of internal initiation of hepatitis C virus RNA translation, EMBO J. 14 (23) (1995) 6010-6020.
[189] D. Rhainds, L. Brissette, The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders, Int. J. Biochem. Cell. Biol. 36 (1) (2004) 39-77.
[190] R. Rijnbrand, P. Bredenbeek, T. van der Straaten, L. Whetter, G. Inchauspe, S. Lemon, W. Spaan, Almost the entire 5' non-translated region of hepatitis C virus is required for cap-independent translation, FEBS Lett. 365 (2-3) (1995) 115-119.
[191] A. Sakai, M. S. Claire, K. Faulk, S. Govindarajan, S. U. Emerson, R. H. Purcell, J. Bukh, The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences, Proc. Natl. Acad. Sci. U. S. A. 100 (20) (2003) 11646-11651.
[192] I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohtaet al., Hepatitis C virus infection is associated with the development of hepatocellular carcinoma, Proc. Natl. Acad. Sci. U. S. A. 87 (17) (1990) 6547-6549.
[193] H. Sakamoto, K. Okamoto, M. Aoki, H. Kato, A. Katsume, A. Ohta, T. Tsukuda, N. Shimma, Y. Aoki, M. Arisawa, M. Kohara, M. Sudoh, Host sphingolipid biosynthesis as a target for hepatitis C virus therapy, Nat. Chem. Biol. 1 (6) (2005) 333-337.
[194] C. Sapin, O. Colard, O. Delmas, C. Tessier, M. Breton, V. Enouf, S. Chwetzoff, J. Ouanich, L. Cohen, C. Wolf, G. Trugnan. Rafts promote assembly and a typical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells. J. Virol. 76 (2002) 4591-4602.
[195] K. Sato, H. Okamoto, S. Aihara, Y. Hoshi, T. Tanaka, S. Mishiro, Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans, Virology 196 (1993) 354-357.
[196] B. Saunier, M. Triyatni, L. Ulianich, P. Maruvada, P. Yen, L. D. Kohn, Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes, J. Virol. 77 (1) (2003) 546-559.
[197] E. Scarselli, H. Ansuini, R. Cerino, R. M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese, A. Vitelli, The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, EMBO J. 21 (19) (2002) 5017-5025.
[198] T.K. Scheel, J.M. Gottwein, T.B. Jensen, J.C. Prentoe, A.M. Hoegh, H.J. Alter, J. Eugen-Olsen, J. Bukh. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A. 105 (3) (2008) 997-1002.
[199] P. Scheiffele, A. Rietveld, T. Wilk, K. Simons. Influenza viruses select ordered lipid domains during budding from the plasma membrane, J Biol Chem、274 (1999) 2038-2044.
[200] J. Schmidt-Mende, E. Bieck, T. Hugle, F. Penin, C. M. Rice, H. E. Blum, D. Moradpour, Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase, J. Biol. Chem. 276 (47) (2001) 44052-44063.
[201] B. Schwer, S. Ren, T. Pietschmann, J. Kartenbeck, K. Kaehlcke, R. Bartenschlager, T. S. Yen, M. Ott, Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif, J. Virol. 78 (15) (2004) 7958-7968.
[202] Y. Sekine-Osajima, N. Sakamoto, K. Mishima, M. Nakagawa, Y. Itsui, M. Tasaka, Y. Nishimura-Sakurai, C.H. Chen, T. Kanai, K. Tsuchiya, T. Wakita, N. Enomoto, Watanabe M. Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. Virology 371 (1) (2008) 71-85.
[203] J. Selby, Q.-L. Choo, K. Berger, G. Kuo, E. Glazer, M. Eckart, C. Lee, D. Chien, C. Kuo, M. Houghton, Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome, J. Gen. Virol. 74 (1993) 1103-1113.
[204] A. Serafino, M. B. Valli, F. Andreola, A. Crema, G. Ravagnan, L. Bertolini, G. Carloni, Suggested role of the Golgi apparatus and endoplasmic reticulum for crucial sites of hepatitis C virus replication in human lymphoblastoid cells infected in vitro, J. Med. Virol. 70 (1) (2003) 31-41.
[205] V. Serebrov, A. M. Pyle, Periodic cycles of RNA unwinding and pausing by hepatitis C virus NS3 helicase, Nature 430 (6998) (2004) 476-480.
[206] S. T. Shi, K. J. Lee, H. Aizaki, S. B. Hwang, M. M. Lai, Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2, J. Virol. 77 (7) (2003) 4160-4168.
[207] T. Shimakami, M. Hijikata, H. Luo, Y. Y. Ma, S. Kaneko, K. Shimotohno, S. Murakami, Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon, J. Virol. 78 (6) (2004) 2738-2748.
[208] T. Shimakami, M. Honda, T. Kusakawa, T. Murata, K. Shimotohno, S. Kaneko, S. Murakami, Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon, J. Virol. 80 (7) (2006) 3332-3340.
[209] Y. K. Shimizu, S. M. Feinstone, M. Kohara, R. H. Purcell, H. Yoshikura, Hepatitis C virus: detection of intracellular virus particles by electron microscopy, Hepatology 23 (1996) 205-209.
[210] T. Shimoike, S. Mimori, H. Tani, Y. Matsuura, T. Miyamura, Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation, J. Virol. 73 (12) (1999) 9718-9725.
[211] T. Shimoike, C. Koyama, K. Murakami, R. Suzuki, Y. Matsuura, T. Miyamura, T. Suzuki, Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein, Virology 345 (2) (2006) 434-445.
[212] Y. Shirota, H. Luo, W. Qin, S. Kaneko, T. Yamashita, K. Kobayashi, S. Murakami, Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity, J. Biol. Chem. 277 (13) (2002) 11149-11155.
[213] K. Simons, E. Ikonen. Functional rafts in cell membranes. Nature 387 (6633) (1997) 569-72.
[214] M. Spahn, J. S. Kieft, R. A. Grassucci, P. A. Penczek, K. Zhou, J. A. Doudna, J. Frank, Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit, Science 291 (5510) (2001) 1959-1962.
[215] E. Steinmann, C. Brohm, S. Kallis, R. Bartenschlager, T. Pietschmann. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol. 82 (2008) 7034-7046.
[216] A.D. Stuart, H.E. Eustace, T.A. McKee, T.D. Brown. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. J Virol. 76 (2002) 9307-9322.
[217] X. Sun, G.R. Whittaker. Role for influenza virus envelope cholesterol in virus entry and infection. J Virol. 77 (2003) 12543-12551.
[218] R. Suzuki, Y. Matsuura, T. Suzuki, A. Ando, J. Chiba, S. Harada, I. Saito, T. Miyamura, Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted, J. Gen. Virol. 76 (1995) 53-61.
[219] R. Suzuki, K. Tamura, J. Li, K. Ishii, Y. Matsuura, T. Miyamura, T. Suzuki, Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus, Virology 280 (2) (2001) 301-309.
[220] R. Suzuki, S. Sakamoto, T. Tsutsumi, A. Rikimaru, K. Tanaka, T. Shimoike, K. Moriishi, T. Iwasaki, K. Mizumoto, Y. Matsuura, T. Miyamura, T. Suzuki, Molecular determinants for subcellular localization of hepatitis C virus core protein, J. Virol. 79 (2) (2005) 1271-1281.
[221] T. Suzuki, R. Suzuki. Maturation and assembly of hepatitis C virus core protein. In: M KalitzkyP Borowski (ed.), Molecular Biology of the Flavivirus, Norfolk, U.K.: Horizon Bioscience, 295-311.
[222] M. Takeda, G.P. Leser, C.J. Russell, R.A. Lamb. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA. 100 (2003) 14610-14617.
[223] T. L. Tan, H. Nakao, Y. He, S. Vijaysri, P. Neddermann, B. L. Jacobs, B. J. Mayer, M. G. Katze, NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling, Proc. Natl. Acad. Sci. U. S. A. 96 (10) (1999) 5533-5538.
[224] T. Tanaka, N. Kato, M.-J. Cho, K. Shimotohno, A novel sequence found at the 3' terminus of hepatitis C virus genome, Biochem. Biophys. Res. Commun. 215 (1995) 744-749.
[225] Y. Tanaka, T. Shimoike, K. Ishii, R. Suzuki, T. Suzuki, H. Ushijima, Y. Matsuura, T. Miyamura, Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome, Virology 270 (1) (2000) 229-236.
[226] Y. Tanji, M. Hijikata, Y. Hirowatari, K. Shimotohno, Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage, J. Virol. 68 (1994) 8418-8422.
[227] T. L. Tellinghuisen, J. Marcotrigiano, A. E. Gorbalenya, C. M. Rice, The NS5A protein of hepatitis C virus is a zinc metalloprotein, J. Biol. Chem. 279 (47) (2004) 48576-48587.
[228] T. L. Tellinghuisen, J. Marcotrigiano, C. M. Rice, Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase, Nature 435 (7040) (2005) 374-379.
[229] T.L. Tellinghuisen, K.L. Foss, J. Treadaway. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog. 4 (3) (2008) e1000032.
[230] J.M. Timpe, Z. Stamataki, A. Jennings, K. Hu, M.J. Farquhar, H.J. Harris, A. Schwarz, I. Desombere, G.L. Roels, P. Balfe, J.A. McKeating. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47 (1) (2008) 17-24.
[231] K. Triantafilou, M. Triantafilou. Lipid raft microdomains : key sites for Coxsackie virus A9 infectious cycle. Virology 317 (2003)128-135.
[232] K. Tsuchihara, T. Tanaka, M. Hijikata, S. Kuge, H. Toyoda, A. Nomoto, N. Yamamoto, K. Shimotohno, Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X, J. Virol. 71 (9) (1997) 6720-6726.
[233] K. Tsukiyama-Kohara, N. Iizuka, M. Kohara, A. Nomoto, Internal ribosome entry site within hepatitis C virus RNA, J. Virol. 66 (1992) 1476-1483
[234] T. Umehara, M. Sudoh, F. Yasui, C. Matsuda, Y. Hayashi, K. Chayama, M. Kohara, Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model, Biochem. Biophys. Res. Commun. 346 (1) (2006) 67-73.
[235] A. Varaklioti, N. Vassilaki, U. Georgopoulou, P. Mavromara, Alternate translation occurs within the core coding region of the hepatitis C viral genome, J. Biol. Chem. 277 (20) (2002) 17713-17721.
[236] S. Vincent, D. Gerlier, S.N. Manie. Measles virus assembly within membrane rafts. J Virol、74 (2000) 9911-9915.
[237] C. Voisset, N. Callens, E. Blanchard, A. Op De Beeck, J. Dubuisson, N. Vu-Dac, High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I, J. Biol. Chem. 280 (9) (2005) 7793-7799.
[238] T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, T. J. Liang, Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nat. Med. 11 (7) (2005) 791-796.
[239] J. L. Walewski, T. R. Keller, D. D. Stump, A. D. Branch, Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame, RNA 7 (5) (2001) 710-721.
[240] C. Wang, P. Sarnow, A. Siddiqui, Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism, J. Virol. 67 (1993) 3338-3344.
[241] T. H. Wang, R. C. Rijnbrand, S. M. Lemon, Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus, J. Virol. 74 (23) (2000) 11347-11358.
[242] G. Waris, S. Sarker, A. Siddiqui, Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex, RNA 10 (2) (2004) 321-329.
[243] K. Watashi, N. Ishii, M. Hijikata, D. Inoue, T. Murata, Y. Miyanari, K. Shimotohno, Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase, Mol. Cell 19 (1) (2005) 111-122.
[244] J. Weiner, M. J. Brauer, J. Rosenblatt, K. H. Richman, J. Tung, K. Crawford, F. Bonino, G. Saracco, Q.-L. Choo, M. Houghton, Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins, Virology 180 (1991) 842-848.
[245] B. Wolk, D. Sansonno, H. G. Krausslich, F. Dammacco, C. M. Rice, H. E. Blum, D. Moradpour, Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines, J. Virol. 74 (5) (2000) 2293-2304.
[246] Z. Xu, J. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindarajan, D. Chien, M. J. Selby, J. Ou, Synthesis of a novel hepatitis C virus protein by ribosomal frameshift, EMBO J. 20 (14) (2001) 3840-3848.
[247] E. Yamada, M. Montoya, C. G. Schuettler, T. P. Hickling, A. W. Tarr, A. Vitelli, J. Dubuisson, A. H. Patel, J. K. Ball, P. Borrow, Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets, J. Gen. Virol. 86 (Pt 9) (2005) 2507-2512.
[248] S. Yan, M. H. Tam, W. J. Syu, Self-association of the C-terminal domain of the hepatitis-C virus core protein, Eur. J. Biochem. 258 (1) (1998) 100-106.
[249] Y. Yan, Y. Li, S. Munshi, V. Sardana, J. L. Cole, M. Sardana, C. Steinkuehler, L. Tomei, R. De Francesco, L. C. Kuo, Z. Chen, Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form, Protein Sci. 7 (4) (1998) 837-847.
[250] Y. Yang, Y. Liang, L. Qu, Z. Chen, M. Yi, K. Li, S.M. Lemon. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A. 104 (17) (2007) 7253-8.
[251] K. Yasui, T. Wakita, K. Tsukiyama-Kohara, S. I. Funahashi, M. Ichikawa, T. Kajita, D. Moradpour, J. R. Wands, M. Kohara, The native form and maturation process of hepatitis C virus core protein, J. Virol. 72 (7) (1998) 6048-6055.
[252] J. Ye, C. Wang, R. Sumpter, Jr., M. S. Brown, J. L. Goldstein, M. Gale, Jr., Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation, Proc. Natl. Acad. Sci. U. S. A. 100 (26) (2003) 15865-15870.
[253] M. Yi, Y. Ma, J. Yates, S.M. Lemon. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol. 81 (2) (2007) 629-38.
[254] M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, T. Fujita. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 5 (7) (2004) 730-7.
[255] M. Yoneyama, M. Kikuchi, K. Matsumoto, T. Imaizumi, M. Miyagishi, K. Taira, E. Foy, Y.M. Loo, M. Gale, S. Akira, S. Yonehara, A. Kato, T. Fujita. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol. 175 (5) (2005) 2851-8.
[256] B. J. Yoo, R. R. Spaete, A. P. Geballe, M. Selby, M. Houghton, J. H. Han, 5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region, Virology 191 (2) (1992) 889-899.
[257] J. Zhang, A. Pekosz, R.A. Lamb. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol. 74 (10) (2000) 4634-44.
[258] J. Zhang, O. Yamada, H. Yoshida, T. Iwai, H. Araki, Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus, Virology 293 (1) (2002) 141-150.
[259] J. Zhang, G. Randall, A. Higginbottom, P. Monk, C. M. Rice, J. A. McKeating, CD81 is required for hepatitis C virus glycoprotein-mediated viral infection, J. Virol. 78 (3) (2004) 1448-1455.
[260] J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, F. V. Chisari, Robust hepatitis C virus infection in vitro, Proc. Natl. Acad. Sci. U. S. A. 102 (26) (2005) 9294-9299.   

Copyright 1998 National Institute of Infectious Diseases, Japan

Top Desktop version